Eating disorders and psychedelic healthcare
Eating disorders, such as anorexia nervosa, bulimia nervosa and binge eating, afflict approximately 20 million people in Europe. In the UK, between one and three million have an eating disorder, with adolescents most at risk.
Conventional treatments are centred around psychotherapy and medical supervision, with antipsychotic and antidepressant medication administered to accelerate recovery. However, in many cases this proves ineffective, with high rates of patient remission.
Up to 85% of those with eating disorders do not respond to medication or therapy, with psychedelic medicines potentially offering new treatment paradigms.READ MORE